Community/Retail

The FDA has approved Difelikefalin injection (Korsuva; Cara Therapeutics and Vifor Pharma) for the treatment of moderate-to-severe chronic kidney disease–associated pruritus in adults undergoing hemodialysis.

Dorzolamide/timolol (Cosopt) is indicated for patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.

Troy Trygstad, PharmD, PhD, MBA, executive director of CPESN USA, discussed how consumers' expectations are changing the future of pharmacy.

Any patients aged 60 years or older who does not meet risk-based recommendations can still receive hepatitis B vaccination.

The approval is based on the results of the ACTIVATE and ACTIVATE-T phase 3 studies, Agios Pharmaceuticals says.

This month's OTC product news features Zinc Complex supplements, Similac 360 Total Care, and Flora Biome Live Probiotic.

Investigators used SC144, an FDA-approved molecule, to find a new pathway for a generation of nonhormonal contraceptives.

Study shows that high infliximab trough levels linked to a low risk of relapse after switching to subcutaneous infliximab in patients with inflammatory bowel disease.

Imodium provides relief of acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel disease.

Maribavir (Livtencity) is indicated for the treatment of adults and pediatric patients with post-transplant cytomegalovirus infection.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses some social and cultural aspects that may contribute to hypoactive sexual desire disorder going untreated in women.

During the period in which Omicron was the dominant variant, the researchers found that fewer patients died while hospitalized compared with those admitted when the Delta variant was dominant.

Alec Smith Insulin Affordability Act provides citizens with a long-term solution to diabetes expenditures.

Experts discuss women's health and health care during the COVID-19 pandemic as part of the Pharmacy Times® Pharmacy Focus webcast series.

At the Day 3 primary endpoint, zuranolone 50 mg co-initiated with a standard of care antidepressant showed a statistically significant reduction in depressive symptoms.

The treatment for hypertrophic cardiomyopathy met its primary endpoint at week 6 in the phase 3 VALOR-HCM trial, the pharmaceutical company says.

Beano helps prevent flatulence, abdominal bloating, and stomach pain.

Finerenone (Kerendia) is indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease.

Sebastian Denison, RPh, BScPharm, said new developments are constantly being published for the use of low-dose naltrexone in patients with inflammatory and autoimmune diseases.

Although marketing may seem intimidating, pharmacy owners should jump in and discover what works best for their pharmacy.

In the report published by The Lancet, the group provides a brief history of drug use and addiction, describes the opioid landscape, and includes 7 recommendations.

Tyler Woods, PharmD, pharmacy district manager with VMC Buying Group, discussed how partnering together can help independent pharmacies obtain drugs at a lower cost.

Jen Diehl, CPA, discussed some common financial concerns for independent pharmacies and where she sees the landscape heading in the future.

Sachin Nagrani, MD, the medical director of Heal, discusses his predictions for the future as we continue to fight the COVID-19 pandemic.

Pharmacists can use these toolkits to answer questions and make clinical designs for medication therapy management services.

Pharmacy technicians are continuing to prove their worth as pharmacies shift their focus to the future, according to Jessica Langley-Loep, executive director of education and advocacy at the National Healthcareer Association.

Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.

Tom Wheelwright, CPA, founder and CEO of WealthAbility, discussed his perspective on taxes and how pharmacies can use them to their advantage.

Although prevention decreased with time, a third booster dose was still highly effective at preventing severe illness with COVID-19.